Schedule 13D ownership disclosure

Solid Biosciences Inc

Common Stock, $0.001 par value per share · CUSIP: 83422E204

Event date: 2026-03-09

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Perceptive Advisors LLCReported CIK 0001224962

    Shares: 11,969,079 · Class: 12.9%

  • Joseph EdelmanReported CIK 0001164426

    Shares: 11,969,079 · Class: 12.9%

  • Perceptive Life Sciences Master Fund, Ltd.Reported CIK 0001249675

    Shares: 11,895,972 · Class: 12.8%

  • Perceptive Xontogeny Venture Fund, LPReported CIK 0001757940

    Shares: 73,107 · Class: 0.1%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-26-102083
Form type
SCHEDULE 13D/A
Filer
PERCEPTIVE ADVISORS LLC
CIK
CIK 1224962
Filed
Mar 11, 2026
Reporting period
Mar 09, 2026
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub